Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,137
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 11,641–11,660 of 17,335 recalls

FDA Recall Terminated Historical recordClass II

ERYTHROMYCIN 2% IN CERAVE CREAM, ERYTHROMYCIN 3% / RETINOIC ACID 0.05%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

CLOBETASOL 0.05% IN OLEA BASE, CLOBETASOL 0.05% IN OROBASE, CLOBETASOL 0.05% OINTMENT, CLOBETASOL 0.05%/ SODIUM, SULFACETAMIDE 10% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

CLINDAMYCIN 1%, AZELAIC ACID 10% CREAM, CLINDAMYCIN 1.2%/ TRETINOIN 0.05% GEL, CLINDAMYCIN 1.2%/ TRETINOIN 0.1% GEL CLINDAMYCIN 2.5%, BENZOYL PEROXIDE 5%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BLEACHING CREAM 0.1% CREAM, BLEACHING CREAM HQ4%, BLEACHING CREAM-NO HQ, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BL 20%/4% CREAM, BLT 20%/6%/4% CREAM, BLT 20%/6%/6%, BLT 20% 8% 4% CREAM, BLT 20% 8% 4% OINTMENT, BLT 20% 8% 6% CREAM, BLT 20%/ 8% /8% OINTMENT, BLT 20%/ 8% /8% CREAM, BLT 20%/ 7%/ 7% CREAM, BLT 20%/ 10%/ 4% CREAM, BLT 20%/ 10%/ 10% CREAM, BLT 20%/ 20%/ 10% OINTMENT,BLT 7%/ 10%/ 7% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BENZOYL PEROXIDE 5% CLINDAMYCIN 1.2%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ADAPALENE 0.1%, BENZOYL PEROXIDE 2.5% GEL, ADAPELENE 0.3%, BENZOYL PEROXIDE 2,5% GEL, AZELAIC ACID 15% CREAM, AZELAIC ACID 20% IN OI FREE CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BICARBONATE 10%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MINOXADIL all strength including 2%, 5% and MINOXIDIL / RETINOIC ACID 5% / 0.025, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

5-FLUOROURACIL IN VANICREAM, FLUOROURACIL in all strengths including 0.05%, 5% CREAM, FLUOROURACIL 4.9% IN CERAVE CREAM, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TACROLIMUS 0.1% Ointment and TACROLIMUS 0.1%/KETOCONAZOLE 2%, Rx only, Synergy Rx, 4901 Morena Blvd #504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

KETOCONAZOLE 2%/HYDROCORTISONE 1.5% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676.

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HCG and HCG with resveratrol Human Chorionic Gonadotropin in different strengths: HCG 300 UNITS/RESVERATROL 50MG S.L. Tablet, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

CANTHARADIN 0.7% SOLUTION and CANTHARIDAN / PODOPHYLLUM SOLUTION, CANTHARIDIN/PODOPHYLLUM RESIN MIXTURE, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin (HCG) 5,000 units/vial and 11,000 units/vial, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

by Synergy Rx

Reason
Lack of Assurance of Sterility: There are also CGMP Deviations.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

PreviDent 5000 ppm, DRY MOUTH, 1.1% Sodium Fluoride, PRESCRIPTION STRENGTH TOOTHPASTE, SLS Free Formula, SOOTHING MINT, 3.4 FL OZ (100 mL), Colgate Oral Pharmaceuticals, Inc., New York, NY 10022 --- NDC 0126-0016-61, UPC 3834110622

by Colgate Palmolive Co

Reason
Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21

by Amerisource Health Services

Reason
Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092.

by G & W Laboratories, Inc.

Reason
CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection, Preservative Free, Rx only, Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109, NDC 70285-1920-1

by Isomeric Pharmacy Solution, LLC

Reason
CGMP Deviations
Published
March 22, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56

by Teva Pharmaceuticals USA

Reason
Failed Impurities/Degradation Specifications
Published
March 22, 2017
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.